Effect of shRNA‑mediated inhibition of Nanog gene expression on the behavior of human gastric cancer cells
- Authors:
View Affiliations
Affiliations: Department of Gastroenterology, First Affiliated Hospital of Chongqing Medical University, YuZhong, Chongqing 400016, P.R. China
- Published online on: June 13, 2013 https://doi.org/10.3892/ol.2013.1394
-
Pages:
367-374
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
The aim of the present study was to employ RNA interference (RNAi) technology to construct and select shRNA‑Nanog recombinant plasmids for the inhibition of Nanog gene expression and transfer these plasmids into the human gastric cancer cell line, SGC‑7901, as well as to detect the expression of Nanog and the effects on the proliferation, migration, invasion, cell cycle and apoptosis of SGC‑7901 cells. The pshRNA‑Nanog interference plasmids were constructed and used to transfect SGC‑7901 cells using lipofectamine. The expression of the Nanog gene was detected by fluorescence microscopy, RT‑PCR and western blotting, and the most markedly inhibited group was identified. The SGC‑7901 cells were transfected with recombinant shRNA‑Nanog plasmids from the most markedly inhibited group using lipofectamine and the effect on proliferation was determined by CCK‑8 assay. The migration and invasion of the SGC‑7901 cells was determined by Transwell assays, while the cell cycle and apoptosis were analyzed by flow cytometry. The group with the highest inhibition rate was successfully constructed and identified. It was observed that the proliferation, invasion and migration capacity of the cells was reduced, that the cell cycle was arrested at the S phase and that apoptosis was significantly increased. The Nanog gene in gastric cancer cells is closely associated with cell proliferation, the cell cycle, apoptosis and migration and invasion abilities. The present study establishes the foundations for a novel approach for the genetic treatment of gastric cancer.
View Figures |
Figure 1
|
|
Figure 2
|
|
Figure 3
|
|
Figure 4
|
|
Figure 5
|
|
Figure 6
|
|
Figure 7
|
|
Figure 8
|
|
Figure 9
|
|
Figure 10
|
View References
1.
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
2.
|
Ezeh UI, Turek PJ, Reijo RA and Clark AK:
Human embryonic stem cell genes cell gene OCT4, NANOG, STELLAR, and
GDF3 are expressed in both seminoma and breast carcinoma. Cancer.
104:2255–2265. 2005. View Article : Google Scholar : PubMed/NCBI
|
3.
|
Hoei-Hansen CE, Almstrup K, Nielsen JE, et
al: Stem cell pluripotency factor NANOG is expressed in human fetal
gonocytes, testicular carcinoma in situ and germ cell tumours.
Histopathology. 47:48–56. 2005. View Article : Google Scholar : PubMed/NCBI
|
4.
|
Pan G and Thomson JA: Nanog and
transcriptional networks in embryonic stem cell pluripotency. Cell
Res. 17:42–49. 2007. View Article : Google Scholar : PubMed/NCBI
|
5.
|
Ye F, Zhou C, Cheng Q, et al:
Stem-cell-abundant proteins Nanog, Nucleostemin and Musashil are
highly expressed in malignant cervical epithelial cells. BMC
Cancer. 8:1082008. View Article : Google Scholar : PubMed/NCBI
|
6.
|
Lin T, Ding YQ and Li JM: Overexpression
of Nanog protein is associated with poor prognosis in gastric
adenocarcinoma. Med Oncol. 29:878–885. 2012. View Article : Google Scholar : PubMed/NCBI
|
7.
|
Chen Z, Xu WR, Qian H, et al: Stem cell
markers Nanog test in the diagnosis of gastric cancer science. J
Clin Laboratory. 27:6–9. 2009.
|
8.
|
Matsuoka J, Yashiro M, Sakurai K, Kubo N,
Tanaka H, Muguruma K, Sawada T, Ohira M and Hirakawa K: Role of the
stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J
Surg Res. 174:130–135. 2012. View Article : Google Scholar : PubMed/NCBI
|
9.
|
Takaishi S, Okumura T and Wang TC: Gastric
cancer stem cells. J Clin Oncol. 26:2876–2882. 2008. View Article : Google Scholar : PubMed/NCBI
|
10.
|
Golestaneh AF, Atashi A, Langroudi L,
Shafiee A, Ghaemi N and Soleimani M: miRNAs expressed differently
in cancer stem cells and cancer cells of human gastric cancer cell
line MKN-45. Cell Biochem Funct. 30:411–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
11.
|
Li X, Fan R, Zou X, et al: Reversal of
multidrug resistance of gastric cancer cells by down-regulation of
CIAPIN1 with CIAPIN1 siRNA. Mol Biol (Mosk). 42:102–109. 2008.(In
Russian).
|
12.
|
Stege A, Priebsch A, Nieth C and Lage H:
Stable and complete overcoming of MDR1/P-glycoprotein-mediated
multidrug resistance in human gastric carcinoma cells by RNA
interference. Cancer Gene Ther. 11:699–706. 2004. View Article : Google Scholar
|
13.
|
Kim DS, Jeon OH, Lee HD, et al: Integrin
alphavbeta3-mediated transcriptional regulation of TIMP-1 in a
human ovarian cancer cell line. Biochem Biophys Res Commun.
377:479–483. 2008. View Article : Google Scholar : PubMed/NCBI
|